+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Marburgvirus Infections Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Marburgvirus Infections

  • ID: 4629665
  • Report
  • September 2018
  • Region: Global
  • 65 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Bavarian Nordic
  • Emergent BioSolutions Inc
  • Emergex Vaccines
  • GeoVax Labs Inc
  • Greffex Inc
  • NanoViricides Inc
  • MORE
Marburgvirus Infections Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Marburgvirus Infections Infection pipeline products.

Report Description

The Marburgvirus Infections Infection pipeline guide presents complete overview of drugs currently being developed for Marburgvirus Infections Infection. The pipeline review provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials).

Drug development phase, current stage, mechanism of action, route of administration, orphan drug/ fast track/ other designations, drug class are provided for each of the Marburgvirus Infections Infection pipeline candidate.

Research and Development progress along with latest news related to each of the Marburgvirus Infections Infection pipeline candidates is included.

Major companies participating in therapeutic development of Marburgvirus Infections Infection are included in this pipeline report. Company wise pre-clinical and clinical products along with details of drug originator, co-developers/ licensors are provided.

Amid strong interest for cure of Marburgvirus Infections Infection from companies and institutes, the current research work serves as a reliable and comprehensive source of information of global Marburgvirus Infections Infection clinical and pre-clinical products.

The report assists in identifying potential upcoming companies and drugs in Marburgvirus Infections Infection pipeline market along with progress of each drug. It also enables users to formulate effective strategies to stay ahead of competition.

Information in the report is sourced from our proprietary platform, built through extensive primary and secondary research methodology. Data is presented in user friendly and ready to use format.

Scope of Marburgvirus Infections Infection pipeline report includes
  • Panorama of Marburgvirus Infections Infection pipeline markets including statistics on therapeutic drugs and companies involved
  • Marburgvirus Infections Infection Pipeline candidates across various development phases including both pre-clinical, discovery and clinical stages are covered
  • Marburgvirus Infections Infection pipeline candidates across various ‘Mechanism of Actions’ are also presented in the study
  • Overview of companies participating in Marburgvirus Infections Infection pipeline with short introduction to their businesses and pipeline projects
  • For each pipeline candidate, drug overview, details of mechanism of Action (MOA), originator, co-developer and licensee are provided.
  • Research and Development progress and trial details, results wherever available, are also included in the pipeline study
  • The pipeline study provides information on all ongoing and active projects and also presents the recent news associated with Marburgvirus Infections Infection pipeline therapeutics
Reasons to Buy
  • Get clear understanding of the entire Marburgvirus Infections Infection pipeline, with details on active projects
  • Get in detail information of each product with updated information on each project along with key milestones
  • Know the list of companies participating in global Marburgvirus Infections Infection pipeline along with progress of each of the company’s products and information on associations/collaborations/licensing data
  • Get trial information for each pipeline product under development
  • Understand the pipeline structure in terms of mechanism of Action, phase and company
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Bavarian Nordic
  • Emergent BioSolutions Inc
  • Emergex Vaccines
  • GeoVax Labs Inc
  • Greffex Inc
  • NanoViricides Inc
  • MORE
I. Key Findings

1. Companies Investing in Marburgvirus Infections Infection Pipeline include-
Number of Companies with Marburgvirus Infections Infection projects in pre-clinical Development-
Number of Companies with Marburgvirus Infections Infection projects in Clinical Development-
Marburgvirus Infections Infection Pipeline Companies based in Americas
Marburgvirus Infections Infection Pipeline Companies based in Europe
Marburgvirus Infections Infection Pipeline Companies based in Asia Pacific
Marburgvirus Infections Infection Pipeline Companies based in Rest of the World

2. Pipeline Candidates include-
Marburgvirus Infections Infection Pipeline Agents in pre- clinical/ Discovery stage of Development
Marburgvirus Infections Infection Pipeline Agents in Clinical Development stage
Marburgvirus Infections Infection Pipeline Therapeutic Compounds received special status
Mechanism of Action of most pipeline Drugs-
Small molecules among the Marburgvirus Infections Infection Pipeline agents

II. Insights into Marburgvirus Infections Infection Pipeline -

1. Disease Overview
Introduction to Marburgvirus Infections Infection
Symptoms and Causes of Marburgvirus Infections Infection
Treatment or Prevention Options for Marburgvirus Infections Infection
Other Details
2. Phase wise Pipeline Compounds
Marburgvirus Infections Infection Pipeline- Pre- Clinical/ Discovery stage Drugs
Marburgvirus Infections Infection Pipeline- Phase 1 stage Drugs
Marburgvirus Infections Infection Pipeline- Phase 2 stage Drugs
Marburgvirus Infections Infection Pipeline- Phase 3 stage Drugs
Marburgvirus Infections Infection Pipeline- Pre-Registration stage Drugs
3. Company wise Marburgvirus Infections Infection Pipeline Compounds
4. Marburgvirus Infections Infection Pipeline by Mechanism of Action

III. Marburgvirus Infections Infection Pipeline Compound Details
  • MVA-BN Filo multivalen
  • BCX4430
  • Pan filovirus
  • filovirus vaccine
  • Quinoxaline-based inhibitors of Ebola and Marburg VP40
  • GEO-EM05
  • trivalent Ebola-Marburg vaccine
  • Marburg VLP Vaccine
  • Bispecific Antibodies for Ebola and Marburg
  • MBP091
  • Small Molecules for Ebola/Marburg
  • PBI-05204
  • VesiculoVax monovalent vaccine
  • VesiculoVax trivalent vaccine
  • TargoVir
Drug Details

1. Snapshot-
Name of the Therapeutic Agent
Originator
Developing Company
Co-Developer/ License Partner
Orphan Drug / Fast Track/ Designation
Development Phase
2. Drug Overview
3. Mechanism of Action
4. Current Status
5. Clinical Trial Details

IV. Marburgvirus Infections Infection Pipeline Company Briefs
  • Bavarian Nordic
  • BioCryst Pharmaceuticals Inc
  • Emergent BioSolutions Inc
  • Emergex Vaccines
  • Fox Chase Chemical Diversity Center Inc.
  • GeoVax Labs Inc
  • Greffex Inc
  • Integrated BioTherapeutics Inc
  • Integrated BioTherapeutics Inc
  • Mapp Biopharmaceutical Inc
  • NanoViricides Inc
  • Phoenix Biotechnology Inc
  • Profectus BioSciences Inc
  • Profectus BioSciences Inc
  • Rodos BioTarget GmbH
V. Latest News and Developments in Global Marburgvirus Infections Infection Pipeline Market

VI. Appendix
1. Publisher's Expertise
2. Research Methodology
3. Contact Information

Some of the sections depicted above may be removed or modified on the basis of information availability"
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Bavarian Nordic
  • BioCryst Pharmaceuticals Inc
  • Emergent BioSolutions Inc
  • Emergex Vaccines
  • Fox Chase Chemical Diversity Center Inc.
  • GeoVax Labs Inc
  • Greffex Inc
  • Integrated BioTherapeutics Inc
  • Mapp Biopharmaceutical Inc
  • NanoViricides Inc
  • Phoenix Biotechnology Inc
  • Profectus BioSciences Inc
  • Rodos BioTarget GmbH
Note: Product cover images may vary from those shown
Adroll
adroll